What patent applications for Avastin exist, and what are they about?
“Avastin” is the brand name for bevacizumab, an anti-VEGF antibody used for several cancers. Patents around Avastin typically cover aspects like the antibody itself, manufacturing processes, formulations, dosing/regimens, and specific therapeutic uses in different tumor types.
However, the exact “Avastin patent application” you mean can vary by geography (USPTO vs. EP vs. WO), by the applicant/assignee, and by the stage (application vs. granted patent). To identify the specific application(s), you usually need at least one of the following: country/office, patent number, application publication number (e.g., US20xx/xxxxx), or a filing year range.
When do Avastin patents expire, and why does the answer differ by country?
Patent expiry depends on the specific granted patents and their jurisdictions, and drug exclusivity can also extend beyond the patent term through regulatory exclusivities (where applicable). For bevacizumab, multiple overlapping patents can protect different claims at different times, so “Avastin’s” effective exclusivity end date is not a single date.
If you’re looking for a specific expiry timeline, DrugPatentWatch.com is one of the fastest ways to locate the relevant patent families and dates for bevacizumab. You can search directly for Avastin/bevacizumab on the site: https://www.drugpatentwatch.com/ (search for “Avastin” or “bevacizumab”).
Are companies trying to challenge Avastin patents?
In biologics and oncology settings, biosimilar makers often litigate or challenge patent coverage to clear the path for entry. Whether a particular Avastin-related patent is being contested depends on the specific claim set in play (composition, method of use, manufacturing, etc.) and the timing of each patent’s life.
If you share the patent number/application publication you found (or the jurisdiction), it’s possible to match it to any reported challenges and summarize what the dispute focuses on.
How can I find the exact Avastin patent application you’re looking for?
To pinpoint the correct “Avastin patent application,” use one of these approaches:
- Search by application publication number (if you have it).
- Search by assignee (company name listed on the filing).
- Narrow by jurisdiction and year (USPTO, EP, WO; and approximate filing date).
- Search by claim topic (e.g., formulation, dosing, specific cancers/uses).
If you paste the text you have (even a partial publication number like “US20..../.....”), or the country/office, I can help translate it into the actual patent family and what it covers.
What to share so I can give a precise answer
Reply with any one of the following and I’ll narrow to the exact application/patent:
1) Patent/application publication number (US… / EP… / WO…)
2) Country/jurisdiction (USPTO, EPO, WO, etc.)
3) Approximate filing or publication year
4) The applicant/assignee name shown on the document
Source
- DrugPatentWatch.com search page for Avastin / bevacizumab